CONMED Shares Outstanding 2010-2024 | CNMD

CONMED shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CONMED Annual Shares Outstanding
(Millions of Shares)
2024 31
2023 32
2022 30
2021 32
2020 29
2019 29
2018 29
2017 28
2016 28
2015 28
2014 28
2013 28
2012 29
2011 29
2010 29
2009 29
CONMED Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 31
2024-09-30 31
2024-06-30 31
2024-03-31 31
2023-12-31 32
2023-09-30 32
2023-06-30 32
2023-03-31 31
2022-12-31 30
2022-09-30 31
2022-06-30 30
2022-03-31 35
2021-12-31 32
2021-09-30 32
2021-06-30 32
2021-03-31 31
2020-12-31 29
2020-09-30 29
2020-06-30 29
2020-03-31 30
2019-12-31 29
2019-09-30 30
2019-06-30 29
2019-03-31 29
2018-12-31 29
2018-09-30 29
2018-06-30 29
2018-03-31 29
2017-12-31 28
2017-09-30 28
2017-06-30 28
2017-03-31 28
2016-12-31 28
2016-09-30 28
2016-06-30 28
2016-03-31 28
2015-12-31 28
2015-09-30 28
2015-06-30 28
2015-03-31 28
2014-12-31 28
2014-09-30 28
2014-06-30 28
2014-03-31 28
2013-12-31 28
2013-09-30 28
2013-06-30 28
2013-03-31 29
2012-12-31 29
2012-09-30 29
2012-06-30 29
2012-03-31 28
2011-12-31 29
2011-09-30 29
2011-06-30 29
2011-03-31 29
2010-12-31 29
2010-09-30 29
2010-06-30 29
2010-03-31 29
2009-12-31 29
2009-09-30 29
2009-06-30 29
2009-03-31 29
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.915B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47